ScienceDex / Researcher record
Geoffrey I. Shapiro
- Dana-Farber Cancer Institute (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $4,000,700 | 6 | #1,628 |
| 2025 | $5,295,164 | 7 | #1,250 |
| 2026 | $21,958,541 | 6 | #150 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected6 records
- FY20257 records
- FY20266 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Citation measures
From OpenAlex data as of September 23, 2026. Google Scholar and Scopus count other sources, so their numbers differ.
Each number opens a page that explains the measure and compares researchers on it.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1941065Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-3331-4095Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing Geoffrey I. Shapiro as a PI. Multi-PI records show the full award amount for context.
- 5UM1CA186709-08UM1Contact PIDana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)$2Maward amount
- 5R01CA285308-02R01Co-investigatorGenetically engineered mouse model to improve therapy of NUT carcinomaBrigham and Women's Hospital · Pathology (investigator's affiliation)$629.2Kaward amount
- $509.8Kaward amount
- 1P01CA269021-01A1P01Contact PITargeting Replication Stress and DNA Damage Response in Uterine Cancer$433.3Kaward amount
- 5R01CA272982-03R01Contact PINovobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers$377.5Kaward amount
- 5P50CA240243-05P50Contact PIDana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant$80.5Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Geoffrey I. Shapiro as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1628
- 2024Entered Top 25% NationallyRanked #1628
- 2024Entered Top 10% NationallyRanked #1628
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$10M Cumulative Funding
- 2026$25M Cumulative Funding
- 2026Entered Top 5% NationallyRanked #150
- 2026Entered Top 1% NationallyRanked #150
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Geoffrey I. Shapiro.